(firstQuint)Specific Use-Result of Spiriva Respimat in Asthmatics.

 The study is Post-Marketing Surveillance on the Long-Term Use of Spiriva Respimat in Japanese patients with mild to moderate persistent asthma.

 The patient population who receive Spiriva Respimat and the safety profile is not expected to change.

 This study can investigate the safety and effectiveness of Spiriva Respimat in patients with mild to moderate persistent asthma under real-world use.

 Specific Use-Result of Spiriva Respimat in Asthmatics@highlight

The study objective is to investigate the safety and effectiveness of Spiriva Respimat in patients with mild to moderate persistent asthma under real-world use